Temporal thermometers grew in popularity during the pandemic, and this isn't the first time that a medical tool important for evaluating Covid-19 patients has been found to not work as well as it should in Black patients. Continue reading →

Clinical intelligence platform partners with one of Southern California's leading multi-specialty medical groups to support patients and care teams SAN FRANCISCO, Sept. 9, 2022 /PRNewswire/ -- Memora Health, the leading technology platform for virtual care delivery and complex care management, today announced a partnership with UP Medical, a multi-specialty medical group, dedicated to raising standards and experience for chronically ill patients, so they can live their best lives. This partnership will leverage Memora's clinical intelligence platform to engage UP Medical patients between visits and reduce the burden of repetitive manual communication on UP Medical's care teams. Continue reading →

MINNEAPOLIS, Sept. Continue reading →

California (United States) Nano Healthcare Technology for Medical Equipment Market research is an intelligence report with meticulous efforts to study the right and valuable information. Continue reading →

GENEVA, Switzerland, Sept. Continue reading →

Though many home care agencies like Bayada were fairly mature in their mobile technology when COVID-19 arrived, Malinowski says the pandemic forced others in the healthcare community, such as hospitals and clinics, to catch up. The most interesting thing thats happened is the velocity of change in digital adoption, where healthcare historically lags, he says Continue reading →

Chicago, Sept. Continue reading →

SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, the developer of the worlds first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced Circulation: Arrhythmia and Electrophysiology has published a peer-reviewed manuscript of the clinical data from a study evaluating the accuracy of its vMap technology. The system, which was cleared by the U.S. Food and Drug Administration in November 2021, demonstrated high accuracy for vMap in identifying arrhythmia sources throughout the heart. Continue reading →

BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode. Continue reading →